Method of decreasing the infectivity of HIV in a biological sample through the administration of S-antithrombin
US7510828B2 · kind B2 · utility
29Cited by
4References
6Claims
0Family size
Inventors
Key dates
| Filing date | Jul 15, 2004 |
| Grant date | Mar 31, 2009 |
| Priority date | — |
| Expiry date | May 7, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention includes compositions comprising substantially purified serpin that are useful in methods for the treatment and prevention of HIV infection. The invention also includes methods for the treatment and prevention of HIV infection comprising contacting a composition of the invention with a human patient or treating HIV infection by introducing into a cell susceptible to HIV infection a DNA molecule encoding a serpin. Additionally, the invention includes antibodies and kits useful in the detection, treatment, and prevention of HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.